Bryostatin 1
Small Intestine Cancer
National Institute on Aging (NIA)Small moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 81/ 100
Competitive context
21 Active assets in the Small Intestine Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide National Cancer Institute (NCI) | Phase 2 | BB |
ETOPOSIDE Cancer Research UK | Phase 2 | BB |
VINCRISTINE SULFATE Cancer Research UK | Phase 2 | BB |
FILGRASTIM Cancer Research UK | Phase 2 | BB |
Inno-206 Cancer Research UK | Phase 2 | B |
View all 50 →
Same molecule, other indications
Bryostatin 1 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →